Neogen (NEOG)

Nasdaq Health Care Health Care Supplies S&P SmallCap 600

$11.76

+0.08 (+0.68%)

Close of Nov 06, 2026 · end-of-day data

Source: Neogen's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$358.28M	$397.93M	$414.19M	$418.17M	$468.46M	$527.16M	$822.45M	$924.20M	$894.70M	$870.40M
Cost of revenue	$189.63M	$211.66M	$222.27M	$221.89M	$253.40M	$284.15M	$416.49M	$460.32M	$473.29M	$461.90M
Gross profit	$168.92M	$186.27M	$191.92M	$196.28M	$215.06M	$243.01M	$405.95M	$463.90M	$421.40M	$408.50M
Research & development	$10.38M	$10.86M	$12.80M	$14.75M	$16.25M	$17.05M	$26.04M	$22.50M	$21.10M	$18.40M
Operating income	$64.94M	$70.19M	$68.09M	$67.52M	$74.17M	$58.62M	$37.52M	$58.60M	-$1.06B	-$21.60M
Interest expense	—	—	—	—	—	—	$27.25M	$42.15M	$38.10M	$24.10M
Pre-tax income	$66.67M	$73.47M	$72.96M	$72.31M	$75.27M	$60.21M	-$22.04M	-$14.30M	-$1.13B	-$9.00M
Income tax	$22.70M	$10.25M	$12.78M	$12.83M	$14.39M	$11.90M	$828.00K	-$4.90M	-$41.10M	-$1.10M
Net income	$43.79M	$63.15M	$60.18M	$59.48M	$60.88M	$48.31M	-$22.87M	-$9.40M	-$1.09B	-$7.90M
EBITDA	$79.64M	$87.25M	$85.72M	$85.92M	$95.21M	$82.31M	$125.89M	$175.30M	-$941.50M	$94.70M
EPS (basic)	$0.87	$1.23	$0.58	$0.57	$0.57	$0.45	$-0.12	$-0.04	$-5.03	$-0.04
EPS (diluted)	$0.86	$1.21	$0.57	$0.56	$0.57	$0.45	$-0.12	$-0.04	$-5.03	$-0.04
Diluted shares	51.16M	52.15M	104.85M	105.72M	107.12M	108.02M	188.88M	216.50M	216.90M	217.50M
Gross margin	47.1%	46.8%	46.3%	46.9%	45.9%	46.1%	49.4%	50.2%	47.1%	46.9%
Operating margin	18.1%	17.6%	16.4%	16.1%	15.8%	11.1%	4.6%	6.3%	-118.6%	-2.5%
Net margin	12.2%	15.9%	14.5%	14.2%	13.0%	9.2%	-2.8%	-1.0%	-122.1%	-0.9%

Balance sheet

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & equivalents	$77.57M	$83.07M	$41.69M	$66.27M	$75.60M	$44.47M	$163.24M	$170.61M	$129.00M	$185.50M
Short-term investments	$66.07M	$127.74M	$225.84M	$277.40M	$305.49M	$336.58M	$82.33M	$325.00K	$0	—
Receivables	$68.58M	$79.09M	$82.58M	$84.68M	$91.82M	$99.67M	$153.25M	$173.00M	$153.40M	$146.80M
Inventory	$73.14M	$76.00M	$85.99M	$95.05M	$100.70M	$122.31M	$133.81M	$189.27M	$190.80M	$144.30M
Total current assets	$292.96M	$375.79M	$449.53M	$537.41M	$591.45M	$626.80M	$585.93M	$589.23M	$576.90M	$604.60M
Goodwill	$104.76M	$99.56M	$103.62M	$110.34M	$131.48M	$142.70M	$2.14B	$2.14B	$1.06B	$1.05B
Total assets	$528.41M	$618.01M	$695.74M	$797.18M	$920.19M	$992.93M	$4.55B	$4.55B	$3.44B	$3.35B
Total current liabilities	$36.00M	$38.69M	$38.25M	$48.49M	$53.60M	$77.84M	$145.47M	$154.32M	$174.00M	$158.20M
Short-term debt	—	—	—	—	—	—	$900.00M	$2.45M	$19.30M	$0
Long-term debt	—	—	—	—	—	$0	$885.44M	$888.39M	$874.80M	$793.70M
Total debt	—	—	—	—	—	$0	$1.79B	$890.84M	$894.10M	$793.70M
Total liabilities	$56.65M	$57.83M	$57.84M	$72.00M	$79.81M	$105.56M	$1.42B	$1.40B	$1.37B	$1.25B
Shareholders' equity	$471.61M	$560.17M	$637.90M	$725.18M	$840.38M	$887.37M	$3.13B	$3.14B	$2.07B	$2.09B

Cash flow

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Operating cash flow	$60.27M	$69.13M	$63.84M	$85.88M	$81.09M	$68.04M	$41.03M	$35.30M	$58.20M	$83.20M
Capital expenditures	$14.58M	$20.95M	$14.66M	$24.05M	$26.71M	$24.43M	$65.76M	$111.40M	$104.60M	$51.30M
Free cash flow	$45.70M	$48.19M	$49.18M	$61.83M	$54.38M	$43.61M	-$24.73M	-$76.10M	-$46.40M	$31.90M
Investing cash flow	-$62.14M	-$83.08M	-$119.15M	-$88.78M	-$105.56M	-$97.23M	$201.04M	-$29.30M	-$99.20M	$70.50M
Financing cash flow	$25.07M	$22.84M	$13.90M	$29.41M	$33.54M	$6.81M	-$118.08M	$1.90M	-$1.60M	-$99.40M
Share buybacks	—	—	$3.13M	—	—	—	—	—	—	—
Stock-based compensation	$5.26M	$4.91M	$5.54M	$6.47M	$6.44M	$7.15M	$10.18M	$13.80M	$17.30M	$13.40M
Depreciation & amortization	$14.69M	$17.06M	$17.62M	$18.40M	$21.04M	$23.69M	$88.38M	$116.70M	$119.50M	$116.30M

Income statement

quarters · USD

Quarter ended	Nov 2023	Feb 2024	May 2024	Aug 2024	Nov 2024	Feb 2025	May 2025	Aug 2025	Nov 2025	Feb 2026	May 2026	Aug 2026
Revenue	$229.63M	$228.81M	$236.77M	$216.96M	$231.26M	$221.00M	$225.50M	$209.20M	$224.69M	$211.20M	$225.30M	$222.80M
Cost of revenue	$112.86M	$111.93M	$123.29M	$112.04M	$117.93M	$110.70M	$132.60M	$114.20M	$118.01M	$112.20M	$117.50M	$117.30M
Gross profit	$116.77M	$116.88M	$113.48M	$104.93M	$113.33M	$110.30M	$92.90M	$95.00M	$106.68M	$99.00M	$107.80M	$105.50M
Research & development	$5.76M	$4.85M	$5.17M	$5.20M	$5.11M	$4.50M	$6.30M	$5.10M	$4.56M	$3.80M	$4.90M	$6.50M
Operating income	$14.46M	$12.02M	$12.98M	$2.26M	-$457.48M	$5.40M	-$611.20M	-$16.10M	-$5.38M	-$3.30M	$3.10M	-$1.80M
Interest expense	$10.27M	$10.50M	$10.79M	—	—	—	—	—	—	—	—	—
Pre-tax income	-$3.75M	-$5.82M	-$6.39M	-$15.61M	-$476.57M	-$9.70M	-$631.20M	$43.80M	-$20.36M	-$20.30M	-$12.10M	-$14.90M
Income tax	-$260.00K	-$3.80M	-$1.00M	-$3.00M	-$20.29M	$1.20M	-$19.00M	$7.50M	-$4.44M	-$3.30M	-$800.00K	-$3.00M
Net income	-$3.49M	-$2.02M	-$5.39M	-$12.61M	-$456.28M	-$10.90M	-$612.20M	$36.30M	-$15.92M	-$17.00M	-$11.30M	-$11.90M
EBITDA	$43.93M	$41.67M	$41.82M	$32.06M	-$427.44M	$34.75M	-$580.90M	$13.00M	$23.50M	$25.62M	$32.50M	$27.30M
EPS (basic)	$-0.02	$-0.01	$-0.02	$-0.06	$-2.10	$-0.05	$-2.82	$0.17	$-0.07	$-0.08	$-0.06	$-0.05
EPS (diluted)	$-0.02	$-0.01	$-0.02	$-0.06	$-2.10	$-0.05	$-2.82	$0.17	$-0.07	$-0.08	$-0.06	$-0.05
Diluted shares	216.41M	216.60M	61.36K	216.70M	216.81M	217.03M	54.22K	217.30M	217.41M	217.67M	-442.35K	218.10M
Gross margin	50.9%	51.1%	47.9%	48.4%	49.0%	49.9%	41.2%	45.4%	47.5%	46.9%	47.8%	47.4%
Operating margin	6.3%	5.3%	5.5%	1.0%	-197.8%	2.4%	-271.0%	-7.7%	-2.4%	-1.6%	1.4%	-0.8%
Net margin	-1.5%	-0.9%	-2.3%	-5.8%	-197.3%	-4.9%	-271.5%	17.4%	-7.1%	-8.0%	-5.0%	-5.3%

Balance sheet

quarters · USD

Quarter ended	Nov 2023	Feb 2024	May 2024	Aug 2024	Nov 2024	Feb 2025	May 2025	Aug 2025	Nov 2025	Feb 2026	May 2026	Aug 2026
Cash & equivalents	$205.76M	$161.44M	$170.61M	$120.48M	$140.23M	$127.70M	$129.00M	$138.88M	$145.34M	$159.90M	$185.50M	$172.00M
Short-term investments	$24.50M	$7.01M	$325.00K	$0	$0	$0	$0	—	—	—	—	—
Receivables	$150.50M	$173.59M	$173.00M	$167.64M	$164.09M	$160.07M	$153.40M	$138.46M	$132.00M	$137.10M	$146.80M	$136.20M
Inventory	$160.53M	$182.39M	$189.27M	$198.60M	$198.27M	$205.44M	$190.80M	$193.41M	$162.77M	$161.70M	$144.30M	$146.10M
Total current assets	$624.37M	$602.47M	$589.23M	$540.65M	$570.45M	$551.71M	$576.90M	$524.06M	$574.58M	$590.00M	$604.60M	$582.50M
Goodwill	$2.14B	$2.14B	$2.14B	$2.14B	$1.67B	$1.67B	$1.06B	$1.07B	$1.05B	$1.05B	$1.05B	$1.05B
Total assets	$4.60B	$4.58B	$4.55B	$4.50B	$4.05B	$4.04B	$3.44B	$3.38B	$3.36B	$3.36B	$3.35B	$3.30B
Total current liabilities	$176.61M	$157.84M	$154.32M	$122.69M	$151.19M	$141.20M	$174.00M	$146.21M	$147.05M	$150.60M	$158.20M	$149.50M
Short-term debt	$2.57M	$2.52M	$2.45M	—	—	—	$19.30M	$800.00M	$800.00M	$800.00M	$0	$780.00M
Long-term debt	$886.91M	$887.65M	$888.39M	$889.13M	$889.87M	$890.61M	$874.80M	$792.53M	$792.93M	$793.30M	$793.70M	$774.20M
Total debt	$889.48M	$890.17M	$890.84M	$889.13M	$889.87M	$890.61M	$894.10M	$1.59B	$1.59B	$1.59B	$793.70M	$1.55B
Total liabilities	$1.45B	$1.44B	$1.40B	$1.37B	$1.39B	$1.38B	$1.37B	$1.26B	$1.26B	$1.26B	$1.25B	$1.22B
Shareholders' equity	$3.15B	$3.15B	$3.14B	$3.14B	$2.67B	$2.66B	$2.07B	$2.12B	$2.10B	$2.10B	$2.09B	$2.09B

Cash flow

quarters · USD

Quarter ended	Nov 2023	Feb 2024	May 2024	Aug 2024	Nov 2024	Feb 2025	May 2025	Aug 2025	Nov 2025	Feb 2026	May 2026	Aug 2026
Operating cash flow	$15.71M	-$30.21M	$26.78M	-$17.91M	$40.25M	$19.46M	$16.40M	$10.80M	$19.50M	$22.70M	$30.20M	$12.90M
Capital expenditures	$24.42M	$32.12M	$24.23M	$38.43M	$17.16M	$32.91M	$16.10M	$24.00M	$11.67M	$11.63M	$4.00M	$8.20M
Free cash flow	-$8.70M	-$62.33M	$2.55M	-$56.35M	$23.10M	-$13.45M	$300.00K	-$13.20M	$7.83M	$11.07M	$26.20M	$4.70M
Investing cash flow	$11.54M	-$14.64M	-$17.51M	-$33.66M	-$17.16M	-$32.48M	-$15.90M	$97.70M	-$11.64M	-$11.56M	-$4.00M	-$8.20M
Financing cash flow	-$310.00K	$1.25M	-$99.00K	$979.00K	-$1.41M	$930.00K	-$2.10M	-$99.40M	-$444.00K	$744.00K	-$300.00K	-$19.00M
Stock-based compensation	$3.51M	$3.68M	$3.97M	$3.98M	$4.82M	$4.20M	$4.30M	$5.00M	$4.30M	$1.10M	$3.00M	$3.10M
Depreciation & amortization	$29.47M	$29.65M	$28.85M	$29.80M	$30.05M	$29.35M	$30.30M	$29.10M	$28.88M	$28.92M	$29.40M	$29.10M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.